genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
DNA
X and Y: Synthorx Expands the Genetic Code to Create Optimized…
Cancer
Set Phase Separation to Stun
Gene Therapy
A New Vision for Gene Therapy
OMICs
Can Encodia Become the Illumina of Proteomics?
Alzheimers
Cognition Thinks It Has an Alzheimer’s Blockbuster
News
Cancer
Lung Cancer Sees New Drug Targets Get “Ironed Out”
Epigenetics
Epigenetic Reset Reverses Age- and Glaucoma Damage-Related Vision Loss in Mice
News
Portable NMR Sensor Detects Fatty Liver Disease and Fibrosis in Mice
CRISPR-Cas9
CRISPR Screening IDs Factors for Turning Stem Cells into Neurons
Bioprocessing
ViGeneron and WuXi Form Strategic Manufacturing Partnership
Insights
All
Trends for 2020
OMICs
Genomics Analysis Moves to the Next Level
December 2020 Vol. 40 No. 12
Viral Clearance in the Manufacture of Biologics
December 2020 Vol. 40 No. 12
Viral Testing in the Era of Continuous Biomanufacturing and COVID-19
December 2020 Vol. 40 No. 12
Viral Safety Testing: Keeping the Fly Out of the Ointment
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Cancer
Lung Cancer Sees New Drug Targets Get “Ironed Out”
Epigenetics
Epigenetic Reset Reverses Age- and Glaucoma Damage-Related Vision Loss in Mice
OMICs
Genomics Analysis Moves to the Next Level
December 2020 Vol. 40 No. 12
Advanced Computational Methods Drive Large-Scale Data Analysis in 4D
Magazine
All
Supplement
November 2020 Vol. 40 No. 11
With Synthetic Biology Nature Is All Business
Biobanking
Biobanks Are Becoming Data Banks in the Era of Personalized Medicine
Biobanking
Cryopreservation to Improve Cell Manufacturing and Biobanking
Biobanking
Enabling Scientific Discovery and Healthcare with Biobanks
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Zinc Finger Nucleases
Zinc Finger Nucleases
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Zinc Finger Nucleases
Novartis Taps Sangamo Zinc Finger Tech for Gene Regulation Therapies
Zinc Finger Nucleases
From Alzheimer’s to Zinc Fingers
Zinc Finger Nucleases
Sangamo Researchers Show Improvements to Zinc Finger Nuclease Technology
Zinc Finger Nucleases
Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition
Zinc Finger Nucleases
Kite, Sangamo Launch Up-to-$3B+ Cancer Cell Therapy Partnership
Zinc Finger Nucleases
Sangamo, Pfizer Partner on Gene Therapy for ALS, FTLD
Zinc Finger Nucleases
Sangamo Genome Editing Trial, Assessing MPS II Candidate, Treats First Patient
Zinc Finger Nucleases
Genetically Engineered Pigs May Fly as Cancer Models
Zinc Finger Nucleases
A Tap of Radiation Enhances Gene Editing of Human Stem Cells
Zinc Finger Nucleases
Gene Editing Technique Boosts Patients’ HIV Resistance
Zinc Finger Nucleases
Genetic Bug Spray? Scientists Alter Mosquitoes’ Sense of Smell
Zinc Finger Nucleases
Sigma Divisions Establish Screening Technology Deals
Zinc Finger Nucleases
Turning on Genes with The Blues
Zinc Finger Nucleases
Synthetic Biology Expands Beyond Bacteria
Zinc Finger Nucleases
Naked ZFNs Point to More Efficient, Safer Gene Therapy
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Sangamo Therapeutics aims to position itself as a leader in the development of chimeric antigen receptor-modified regulatory T-cell (CAR-Treg) cell therapies for immunological diseases with its planned acquisition of TxCell. [Source: TxCell]](https://www.genengnews.com/wp-content/uploads/2018/08/ENTrIA_recognition_EN_without_entria1024x9291472362223-265x198.png "Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition")
